Literature DB >> 15163225

Laboratory and clinical aspects of B-type natriuretic peptides.

Ronald J Elin1, William E Winter.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 15163225     DOI: 10.5858/2004-128-697-LACAOB

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


× No keyword cloud information.
  6 in total

1.  Pediatric brain natriuretic peptide and N-terminal pro-brain natriuretic peptide reference intervals.

Authors:  Steven J Soldin; Offie P Soldin; Alanna J Boyajian; Madeline S Taskier
Journal:  Clin Chim Acta       Date:  2005-12-19       Impact factor: 3.786

Review 2.  Clinical applications of N-terminal pro B-type natriuretic peptide in heart failure and other cardiovascular diseases.

Authors:  Da-Rong Pu; Jun R Chiong; Qi-chang Zhou
Journal:  Heart Fail Rev       Date:  2010-07       Impact factor: 4.214

3.  Exercise limitation in IPF patients: a randomized trial of pulmonary rehabilitation.

Authors:  Robert M Jackson; Orlando W Gómez-Marín; Carol F Ramos; Constanza M Sol; Meryl I Cohen; Ignacio A Gaunaurd; Lawrence P Cahalin; Diana D Cardenas
Journal:  Lung       Date:  2014-04-05       Impact factor: 2.584

4.  Relationship between CCR and NT-proBNP in Chinese HF patients, and their correlations with severity of HF.

Authors:  Zhigang Lu; Bo Wang; Yunliang Wang; Xueqing Qian; Wei Zheng; Meng Wei
Journal:  Biomed Res Int       Date:  2014-08-28       Impact factor: 3.411

5.  Acute Cardiorenal Syndrome Type 1 in Patients With Congestive Heart Failure Exacerbations Is Not an Indicator of Poor Outcome and Increased Mortality.

Authors:  Eric Arguelles; Carolina de Elia; Zoran Lasic
Journal:  Cardiol Res       Date:  2014-05-15

6.  Comparing serum levels of cardiac biomarkers in cancer patients receiving chemotherapy and subjects with chronic periodontitis.

Authors:  WingsT Y Loo; Yuan Yue; Chang-bin Fan; Lan-jun Bai; Yi-ding Dou; Min Wang; Hao Liang; Mary N B Cheung; Louis W C Chow; Jin-le Li; Ye Tian; Liu Qing
Journal:  J Transl Med       Date:  2012-09-19       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.